LINDSEY CLICKNER: Open Payments
NPI 1679021729 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 27 payments from 7 companies in 2025. Trend: 2023 $457 · 2024 $790 · 2025 $536
Food & beverage: $523Education: $12
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $221 |
| Lilly USA, LLC | 8 | $121 |
| Gilead Sciences, Inc. | 4 | $68 |
| Abbott Laboratories | 3 | $57 |
| SANOFI-AVENTIS U.S. LLC | 1 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Amgen Inc. | 1 | $17 |
Products named: MOUNJARO, Rybelsus, Ozempic, FREESTYLE LIBRE 3, TZIELD, XIFAXAN.
Industry payments across KY — which companies pay providers there.
